Cannabis species and cannabinoid concentration preference among sleep-disturbed medicinal cannabis users

Addictive Behaviors

Volumn 50, Issue , 2015, Pages 178-181

  Belendiuk, Katherine A ^a   Babson, Kimberly A ^b   Vandrey, Ryan ^c   Bonn Miller, Marcel O ^b,d,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cannabis; Insomnia; Marijuana; Medical marijuana; Sleep

Indexed keywords

CANNABINOID; MEDICAL CANNABIS; CANNABIS; HYPNOTIC SEDATIVE AGENT;

ADULT; ARTICLE; CANNABIS ADDICTION; CANNABIS USE; DSM-5; FEMALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NIGHTMARE; SELF REPORT; SLEEP; SLEEP DISORDER; SLEEP QUALITY; ADOLESCENT; AGED; CALIFORNIA; COMORBIDITY; DREAM; DRUG EFFECTS; MARIJUANA ABUSE; MIDDLE AGED; SLEEP INITIATION AND MAINTENANCE DISORDERS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CALIFORNIA; CANNABINOIDS; CANNABIS; COMORBIDITY; DREAMS; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MARIJUANA ABUSE; MEDICAL MARIJUANA; MIDDLE AGED; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; YOUNG ADULT;

EID: 84934766407     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2015.06.032     Document Type: Article

References (18)

1. Aizpurua-Olaizola O., Omar J., Navarro P., Olivares M., Etxebarria N., Usobiaga A. Identification and quantification of cannabinoids in Cannabis sativa L. plants by high performance liquid chromatography-mass spectrometry. Analytical and Bioanalytical Chemistry 2014, 406:7549-7560.
2. Babson K.A., Bonn-Miller M.O. Sleep disturbances: Implications for cannabis use, cannabis use cessation, and cannabis use treatment. Current Addiction Reports 2014, 1:109-114.
3. Backhaus J., Junghanns K., Broocks A., Riemann D., Hohagen F. Test-retest reliability and validity of the Pittsburgh Sleep Quality Index in primary insomnia. Journal of Psychosomatic Research 2002, 53:737-740.
4. Bonn-Miller M.O., Babson K.A., Vandrey R. Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with PTSD. Drug and Alcohol Dependence 2014, 136:162-165.
5. Bonn-Miller M.O., Boden M.T., Bucossi M.M., Babson K.A. Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users. American Journal of Drug and Alcohol Abuse 2014, 40:23-30.
6. Budney A.J., Hughes J.R., Moore B.A., Vandrey R. Review of the validity and significance of cannabis withdrawal syndrome. The American Journal of Psychiatry 2004, 161:1967-1977.
7. Burgdorf J.R., Kilmer B., Pacula R.L. Heterogeneity in the composition of marijuana seized in California. Drug and Alcohol Dependence 2011, 117:59-61.
8. Buysse D.J., Reynolds C.F., Monk T.H., Berman S.R., Kupfer D.J. The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Research 1989, 28:193-213.
9. Compton W.M., Grant B.F., Colliver J.D., Glantz M.D., Stinson F.S. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA 2004, 291:2114-2121.
10. Englund A., Morrison P.D., Nottage J., Hague D., Kane F., Bonaccorso S., et al. Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. Journal of Psychopharmacology 2013, 27:19-27.
11. First M.B., Spitzer R.L., Gibbon M., Williams J. Structured Clinical Interview for DSM-IV axis I disorders- non-patient edition 1995, New York State Psychiatric Institute, New York.
12. Grella C.E., Rodriguez L., Kim T. Patterns of medical marijuana use among individuals sampled from medical marijuana dispensaries in Los Angeles. Journal of Psychoactive Drugs 2014, 46:263-272.
13. Hillig K.W., Mahlberg P.G. A chemotaxonomic analysis of cannabinoid variation in Cannabis (cannabaceae). American Journal of Botany 2004, 91:966-975.
14. Mitchell G. Revisiting truth or triviality: The external validity of research in the psychological laboratory. Perspectives on Psychological Science 2012, 7:109-117.
15. Russo E.B. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology 2011, 163:1344-1364.
16. Vann R.E., Gamage T.F., Warner J.A., Marshall E.M., Taylor N.L., Martin B.R., et al. Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of δ(9)-tetrahydrocannabinol. Drug and Alcohol Dependence 2008, 94:191-198.
17. Walsh Z., Callaway R., Belle-Isle L., Capler R., Kay R., Lucas P., et al. Cannabis for therapeutic purposes: Patient characteristics, access, and reasons for use. International Journal of Drug Policy 2013, 24:511-516.
18. Zuardi A.W., Hallak J.E., Crippa J.A. Interaction between cannabidiol (CBD) and δ(9)-tetrahydrocannabinol (THC): influence of administration interval and dose ratio between the cannabinoids. Psychopharmacology 2012, 219:247-249.